Clinical Trial Update: Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluated the safety and immunogenicity of a naked DNA-based vaccine therapy in adults with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Naked DNA-based vaccine therapy

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED